222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details


臨床試験数 : 285 薬物数 : 285 - (DrugBank : 108) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 191

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00001959
(ClinicalTrials.gov)
December 199918/1/2000Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II StudyFibrosis;Focal Glomerulosclerosis;Kidney Failure;Nephrotic Syndrome;ProteinuriaDrug: PirfenidoneNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NULLCompleted18 YearsN/AAll21Phase 2United States